EBEWE Pharma

EBEWE Pharma is an Austrian pharmaceutical company specializing in the development and manufacture of injectable generic medicines, with a primary focus on oncology. Founded in 1945 and headquartered in Unterach, the company has established itself as a global leader in specialty injectables, providing a broad portfolio of chemotherapy agents and bone health treatments. In 2009, EBEWE Pharma was acquired by Sandoz, the generics division of Novartis, to serve as its global center of excellence for generic oncology injectables. The company operates state-of-the-art manufacturing facilities that comply with international GMP standards, supplying essential medicines to over 100 countries. Its product range includes well-known agents such as methotrexate, paclitaxel, and oxaliplatin, supporting both cancer treatment and immunology.